Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morton Coleman

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Clinical Lymphoma & Myeloma|June 16, 2009
Durable complete remissions in HIV-associated Hodgkin lymphoma after treatment with only one cycle of chemotherapy complicated by sepsisPeter Martin, John P Leonard, Morton Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Phase I to III trials of anti-B cell therapy in non-Hodgkin's lymphomaPeter Martin, Richard R Furman, Morton Coleman, et al.
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
The role of FDG-PET imaging in the management of lymphomaLale Kostakoglu, John P Leonard, Morton Coleman, et al.
Current Oncology Reports|August 11, 2005
New developments in immunotherapy for non-Hodgkin's lymphomaJohn P Leonard, Richard R Furman, Jia Ruan, et al.
Clinical Lymphoma & Myeloma|August 2, 2006
Lymphoma in elderly patients: novel functional assessment techniques provide better discrimination among patients than traditional performance status measuresAbby B Siegel, Mark Lachs, Morton Coleman, et al.
The Oncologist|February 15, 2005
The role of mitoxantrone in the treatment of indolent lymphomasFredrick Hagemeister, Fernando Cabanillas, Morton Coleman, et al.
Hematology (Amsterdam, Netherlands)|April 18, 2012
Metronomic therapy for refractory/relapsed lymphoma: the PEP-C low-dose oral combination chemotherapy regimenMorton Coleman, Gia Ruan, Rebecca L Elstrom, et al.
Seminars in Oncology|August 27, 2003
CD22-directed monoclonal antibody therapy for lymphomaAbby B Siegel, David M Goldenberg, Alessandra Cesano, et al.
Annals of Diagnostic Pathology|November 18, 2017
Oral Lymphomatoid papulosis type C: A diagnostic pitfall, often confused with T-cell lymphomaZiv Schwartz, Morton Coleman, Jennifer P Toyohara, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 21, 2006
Case report: lymphoma arising in an ileal pouch anal anastomosis after immunomodulatory therapy for inflammatory bowel diseaseLauren K Schwartz, Michelle Kang Kim, Morton Coleman, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Clinical Lymphoma & Myeloma|June 16, 2009
Durable complete remissions in HIV-associated Hodgkin lymphoma after treatment with only one cycle of chemotherapy complicated by sepsisPeter Martin, John P Leonard, Morton Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Phase I to III trials of anti-B cell therapy in non-Hodgkin's lymphomaPeter Martin, Richard R Furman, Morton Coleman, et al.
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
The role of FDG-PET imaging in the management of lymphomaLale Kostakoglu, John P Leonard, Morton Coleman, et al.
Current Oncology Reports|August 11, 2005
New developments in immunotherapy for non-Hodgkin's lymphomaJohn P Leonard, Richard R Furman, Jia Ruan, et al.
Clinical Lymphoma & Myeloma|August 2, 2006
Lymphoma in elderly patients: novel functional assessment techniques provide better discrimination among patients than traditional performance status measuresAbby B Siegel, Mark Lachs, Morton Coleman, et al.
The Oncologist|February 15, 2005
The role of mitoxantrone in the treatment of indolent lymphomasFredrick Hagemeister, Fernando Cabanillas, Morton Coleman, et al.
Hematology (Amsterdam, Netherlands)|April 18, 2012
Metronomic therapy for refractory/relapsed lymphoma: the PEP-C low-dose oral combination chemotherapy regimenMorton Coleman, Gia Ruan, Rebecca L Elstrom, et al.
Seminars in Oncology|August 27, 2003
CD22-directed monoclonal antibody therapy for lymphomaAbby B Siegel, David M Goldenberg, Alessandra Cesano, et al.
Annals of Diagnostic Pathology|November 18, 2017
Oral Lymphomatoid papulosis type C: A diagnostic pitfall, often confused with T-cell lymphomaZiv Schwartz, Morton Coleman, Jennifer P Toyohara, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 21, 2006
Case report: lymphoma arising in an ileal pouch anal anastomosis after immunomodulatory therapy for inflammatory bowel diseaseLauren K Schwartz, Michelle Kang Kim, Morton Coleman, et al.
Pageof 12